{"id": "1356216467646263299", "creation": 1612182177.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "\u201cWhile #India has vast ambitions for its vaccines on the global stage, reception at home has been mixed. #Covaxin, the #vaccine developed by @BharatBiotech, was approved for emergency use without phase 3 trial data, prompting criticism that the process was rushed.\u201d \ud83e\udd14 #COVID19 https://t.co/vLjnUZOSVW", "first_save": 1634559108.199414, "hashtags": ["#INDIA", "#COVAXIN", "#VACCINE", "#COVID19"]}